These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 33200795)
1. C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload. Wang X; Li W; Yue Q; Du W; Li Y; Liu F; Yang L; Xu L; Zhao R; Hu J Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200795 [TBL] [Abstract][Full Text] [Related]
2. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling. Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511 [TBL] [Abstract][Full Text] [Related]
3. Alamandine improves cardiac remodeling induced by transverse aortic constriction in mice. Silva MM; de Souza-Neto FP; Jesus ICG; Gonçalves GK; Santuchi MC; Sanches BL; de Alcântara-Leonídio TC; Melo MB; Vieira MAR; Guatimosim S; Santos RAS; da Silva RF Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H352-H363. PubMed ID: 33124885 [TBL] [Abstract][Full Text] [Related]
4. Loss of ADAM15 in female mice does not worsen pressure overload cardiomyopathy, independent of ovarian hormones. Krishnan V; Atanasova N; Aujla PK; Hupka D; Owen CA; Kassiri Z Am J Physiol Heart Circ Physiol; 2024 Aug; 327(2):H409-H416. PubMed ID: 38607341 [TBL] [Abstract][Full Text] [Related]
5. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload. You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344 [TBL] [Abstract][Full Text] [Related]
6. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction. Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865 [TBL] [Abstract][Full Text] [Related]
7. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin. Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763 [TBL] [Abstract][Full Text] [Related]
8. MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart. Nawaito SA; Dingar D; Sahadevan P; Hussein B; Sahmi F; Shi Y; Gillis MA; Gaestel M; Tardif JC; Allen BG Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H46-H58. PubMed ID: 28432058 [TBL] [Abstract][Full Text] [Related]
9. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload. Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642 [TBL] [Abstract][Full Text] [Related]
10. Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload. Shi L; Zhu D; Wang S; Jiang A; Li F Am J Hypertens; 2019 Apr; 32(5):452-459. PubMed ID: 30689697 [TBL] [Abstract][Full Text] [Related]
12. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice. Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112 [TBL] [Abstract][Full Text] [Related]
14. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery. Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510 [TBL] [Abstract][Full Text] [Related]
15. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload. Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822 [TBL] [Abstract][Full Text] [Related]
16. Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice. Nemska S; Gassmann M; Bang ML; Frossard N; Tavakoli R J Cardiovasc Pharmacol; 2021 Dec; 78(6):792-801. PubMed ID: 34882111 [TBL] [Abstract][Full Text] [Related]
17. Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice. Ogita H; Node K; Liao Y; Ishikura F; Beppu S; Asanuma H; Sanada S; Takashima S; Minamino T; Hori M; Kitakaze M Hypertension; 2004 Feb; 43(2):237-42. PubMed ID: 14676219 [TBL] [Abstract][Full Text] [Related]
18. Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy. Chen H; Wang X; Tong M; Wu D; Wu S; Chen J; Wang X; Wang X; Kang Y; Tang H; Tang C; Jiang W PLoS One; 2013; 8(5):e64757. PubMed ID: 23737997 [TBL] [Abstract][Full Text] [Related]
19. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress. Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424 [TBL] [Abstract][Full Text] [Related]
20. In vivo cardiac role of migfilin during experimental pressure overload. Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]